Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Annual Report
2019Achieving our Strategic Goals Summary of Activities and Progress (July 2018 – June 2019)
College Values That Drive What We DoCommitment to Best PracticeExemplified through an evidence-based culture, a focus on patient outcomes and equity of access to high quality care; an attitude of compassion and empathy.
Acting with IntegrityExemplified through an ethical approach: doing what is right, not what is expedient; a forward thinking and collaborative attitude and a patient-centric focus.
AccountabilityExemplified through strong leadership that is accountable to members; patient engagement at professional and organisational levels.
LeadershipExemplified through a culture of leadership where we demonstrate outcomes.
Board of Directors
Dr Lance Lawler President
Dr Brigid Hickey Elected Fellow
Clin A/Prof Sanjay Jeganathan Dean, Faculty of Clinical Radiology
Dr Peter Pratten Elected Fellow
Dr Madhavi Chilkuri Dean, Faculty of Radiation Oncology
Dr Yvonne Ho Elected Fellow
Dr Gabriel Lau Chair, New Zealand Branch
Prof Vin Massaro Non-Fellow
THE COLLEGEOur
Vision
Our
Purpose
RANZCR leading best practice in clinical radiology and radiation oncology for the benefit of our patients and society.
To drive the safe and appropriate use of radiology and radiation oncology to optimise health outcomes through leadership, education and advocacy.
The Royal Australian and New Zealand College of Radiologists (RANZCR)
2 I ANNUAL REPORT 2019 THE COLLEGE
A Message from the President
At last year’s ASM in Canberra, Nobel Laureate Prof Brian Schmidt, spoke eloquently about the future and how we should best deal with our inability to predict it well. With another year now under our belts, we can reflect on the work we have done to create the future that we wish to see.
The year saw many successes that were as much a result of our efforts over the last few years to shift the College from its more inward focus as they were of the dedicated staff and volunteers creating the right conditions to achieve this success.
In this year alone, this intensified effort included over 20 submissions and a record number of meetings with Ministers and Shadow Ministers, in both Australia and New Zealand. This engagement has also resulted in governments and agencies regularly consulting with the College for its expertise, insight and input on both policy-related and other matters. RANZCR is now widely recognised as the peak body for clinical radiology and radiation oncology in Australia and New Zealand, and a respected voice elsewhere.
Though our list of achievements for the year is long, we must never forget that complacency is the enemy and continuously reassess and refocus our efforts when appropriate. The College continues to devote resources to promote the role of our two specialties, lobbying government to improve access and affordability in healthcare, and addressing the impact of Artificial Intelligence (AI) on our professions. RANZCR recently co-hosted the first ever Radiation Oncology Horizon Summit in New Zealand with Health Minister, the Hon Dr David Clark. The event emphasised the current underutilisation of this lifesaving treatment and has kick-started the process of developing new Government policies. The College has also provided a comprehensive response to New Zealand’s Health and Disability Review for both clinical radiology and radiation oncology.
Among our other advocacy achievements in Australia were increased funding in 2018–19 for specialist training program (STP) posts, additional MRI licences, and new Medicare items covering 3D breast tomosynthesis and a range of MRI scans, including certain obstetric, cardiac and liver cases, and the diagnosis of prostate cancer. You can read more about our achievements on page six of this annual report. The need for advocacy is unending, and despite the positives that came out of the recent Australian Federal Election the work continues. New Zealand will be holding their next federal election in 2020 and we will continue to look for opportunities to improve patient outcomes in our specialities. In these initiatives and many others, the College is playing a long form of the advocacy game, working towards the goal of becoming a 'trusted adviser.'
Beyond the advocacy efforts, our work in AI has been widely recognised. RANZCR was the first professional healthcare body in the world to develop Ethical Principles for Artificial Intelligence (AI) in Medicine.
The principles have been downloaded from our website more than 1,500 times, making it our most viewed document in 2019.
This work continues to proceed whilst at the same time, the College continues to move towards achieving the goals of our 2021 strategy. I am encouraged in the knowledge that we are taking the right steps to tackle the coming challenges. Striving to improve helps the College focus on the future of our profession, and surely, we need to remain focused if we want to have a future. As I have said in the past, the market for our professional services is among the most competitive in healthcare, and our funding streams and the health policies that affect us are under constant review. Whether in terms of technological innovation or competing service models, no medical specialist has as much at stake as the radiologists and radiation oncologists.
The Board and the College management team know these hard realities well and we will continue to keep this in mind as we focus on creating another successful year.
Dr Lance Lawler
PRESIDENT REPORT ANNUAL REPORT 2019 I 3
CEO presents… a year at a glance
108 Fellows
participated in MBS Review
JMIRO Impact Factor 1.2
149 NEW FELLOWS
17 new Educational Affiliates
152 NEW
TRAINEES
93%
of respondents rated their interaction with
the College satisfactory /highly satisfactory
142,866 users
170,586 sessions
248,412 page views
1,574,121 users
1,810,631 sessions
2,162,890 page views
TARGETING CANCER WEBSITE
INSIDERADIOLOGY WEBSITE
3,226 followers on Twitter
4,476 likes on Facebook
2,578 followers on LinkedIn
COLLEGE SOCIAL MEDIA
4,080 followers on Twitter
Twitter Engagements 361,5002,968 followers on Facebook
Facebook Reach 279,228448 followers on LinkedIn
TARGETING CANCER SOCIAL MEDIA
RANZCR WEBSITE
163,594 users
346,674 sessions
823,645 page views
The College ONLINE
RANZCR Research Grants Awarded
Clinical Radiology $59,125Radiation Oncology $59,978
The highest ever media coverage for the College
total audience reached: 5,385,865
388% increase
from 2017/18
4 I ANNUAL REPORT 2019 YEAR AT A GLANCE
Member DEMOGRAPHICS
GENDER:
3,462 Fellows (including 99 Life members)
775 Students
119 Educational
Affiliates
6 Associate members
1,381 female
3,084 male
TOTAL NO. MEMBERS:
4,486
TYPE:
SPECIALTY:
698 Radiation Oncologists
3,785 Clinical Radiologists
A snapshot of some of the ways in which our members engaged with College activities in 2018/19
Members donating to our Education and Research Fund and
the JP Trainor Archive Trust:
90
Participated in Special Interest Groups and Reference Groups:
1,530
Sitting on our committees, panels and
working groups:
744
Sitting on the Board and
Faculty Councils:
45
CONTRIBUTING TO OUR PUBLICATIONS
JMIRO:
1 Editor in Chief
2 Deputy Editors
34 Associate Editors
240 Reviewers
Inside News:
1 Editor in Chief
17 Contributors
NUMBER SUPPORTING
OUR TRAINING PROGRAM
6 Network Training
Directors (Radiology only)
8 Training Network
Directors (Radiation Oncology only)
8 Branch Education
Officers (Radiology only)
20 IMG Assessors
10 Training Site Accreditation
Assessors
189 Directors
of Training
161 RANZCR Examiners
LOCATION:
ACT
84
QLD
714
NZ
665
NSW
1,166VIC
921
TAS
69NT
6
WA
362SA
294
Overseas 193
CREDENTIALING
CT Coronary Angiography (CTCA)
As at 30 June 2019, there are:
572 registered CTCA Specialists
Level A CTCA: 394Level B CTCA: 178
(including radiologists, cardiologists and nuclear medicine specialists)
CT Colonography (CTC)
As at 30 June 2019 there are:
329 registered CTC Specialists (including radiologists only)
Interventional Neuroradiology (INR)
As at 30 June 2019 there are:
51 recognised INR Specialists
(including radiologists, nuerologists and neurosurgeons)
Cardiac MRI
As at 30 June 2019 there are:
100 registered Cardiac MRI Specialists
(including radiologists and cardiologists)
EVENT Attendance
1,035 delegates attended the 2018 Annual Scientific Meeting
255 delegates attended the 2018 NZ Branch Annual Scientific Meeting
168 delegates attended the Intelligence 18 Event
117 delegates attended the 2018 ACR Courses
24 delegates attended the 2019 FRO Phase 2 Exam Preparation Course
32 delegates attended the 2019 FRO Phase 1 Exam Preparation Course
31 delegates attended the 2019 FRO Phase 1 Foundation Course
38 delegates attended the 2019 FRO SMART Workshop
YEAR AT A GLANCE ANNUAL REPORT 2019 I 5
Record number of meetings (39) with Ministers and Shadow Ministers in both Australia and New Zealand.
RANZCR provided a comprehensive response to New Zealand’s Health
and Disability Review for both clinical radiology and radiation oncology.
Played a significant role in securing Australian Government commitment to additional funding for breast MRI as part of the treatment of breast cancer.
RANZCR was the first professional healthcare body in the world to develop Ethical Principles for Artificial Intelligence (AI) in Medicine. The principles have been downloaded from our website more than 1,500 times, making it our most viewed document ever.
The Australian Government committed $375 million over four years, to expand access to Medicare-eligible MRI machines. They also committed to working with RANZCR to further expand
access to this important life-saving technology, including evaluation of the additional 53 MRI licences.
RANZCR co-hosted the first ever Radiation Oncology Horizon Summit in
New Zealand with Health Minister, the Hon Dr David Clark. The event emphasised the
current underutilisation of this lifesaving treatment and has kick-started the process of developing new Government policies.
Responded to several consultations on AI including CSIRO’s Ethical Framework Discussion Paper, the Therapeutic Goods Administration (TGA) consultation on the Regulation of Software as a Medical Device, the Australian Human Rights Commission consultation on AI and the NZ Therapeutic Products Bill.
The Australian Government announced indexation of ultrasound and X-ray services, following advocacy by RANZCR and Australian Diagnostic Imaging Association (ADIA).
This year RANZCR developed an Australian federal election survey to promote our advocacy priorities. The Coalition, Labor, Australian Greens and Central Alliance all completed the survey. As a result, RANZCR received commitments from all parties to:
o Develop a comprehensive strategy to prepare for the adoption of artificial intelligence (AI) in healthcare
o Support access to particle therapy, including the creation of a nationally coordinated plan for particle therapy, and
o Support the MBS Review Taskforce recommendation to fund detailed modelling and a pilot of the proposed changes to the MBS Radiation Oncology Schedule.
Key achievements of the year
6 I ANNUAL REPORT 2019 ACHIEVEMENTS
We were instrumental in the Australian Government listing of liver MRI saving patients up to $800 for a MRI scan which can help detect liver cancer more effectively.
RANZCR and other key stakeholders worked to secure $68 million to improve cancer care for patients in regional Australia through investing in new radiation therapy facilities.
The highest ever media coverage for the College, total audience reached: 5,385,865 (a 388% increase from 2017/18).
RANZCR led the Australian Medical Services Advisory Committee application for the new Medicare item for foetal MRI improving access to and affordability of this vital scan for pregnant women.
RANZCR has been a proactive contributor to the Medicare Benefits Schedule (MBS) Review and provided valuable feedback to all reports that impact on our sectors. The Department of Health has described RANZCR as the “outstanding contributor” to the Review process.
An increase in proactive media activities, including editorials published in the Medical Observer, Australian Doctor and NZ Doctor.
RANZCR has been invited by the Australian Department of Health (DoH) to participate in several Implementation Liaison Groups to support the implementation of changes from the MBS Review Taskforce.
Proactive TV feature stories raised the profile of the Targeting Cancer campaign which supported the Midnight Rambler crew in the Sydney to Hobart yacht race.
Submission of 2019 RANZCR Reaccreditation submission to Australian Medical Council (AMC) and Medical Council of New Zealand (MCNZ).
33 Specialist Training Program (STP) applications (predominantly Clinical Radiology) received in the Department of Health’s November Expression of Interest.
The inaugural Network Training Development Forums were held for Clinical Radiology and Radiation Oncology, providing a greater focus on the requirements
of the network training program, accreditation and STP.
Examiner Code of Conduct approved.
ACHIEVEMENTS ANNUAL REPORT 2019 I 7
Part 1 examination reforms have been finalised and approved with other exam changes approved. Implementation intending to commence in 2021.
Implementation of enhanced training programs has commenced and is progressing according to the plan.
Training at new regional and private settings has increased as a result of the STP; each network now has a regional rotation.
Both TAR Steering Committee have made steady progress in the Training and Assessment Reform, with the enhanced training program
expected to be completed by end of September 2019.
Reviewed and adjusted accreditation report structure for both faculties
Review of IMG processes to align with MBA Good Practice Guidelines
Professional Document publication
Version 11 CR Standards of Practice
Interventional Radiology White Paper
Framework for Recognition of Training in Percutaneous Stroke Intervention
Policy on the use of Thermography to detect Breast Cancer position statement – Sep 2018
Imaging of Breast implant associated Anaplastic Large Cell Lymphoma position statement – Nov 2018
Molecular Breast Imaging / Breast Specific Gamma Imaging position statement – Jun 2019
Breast Imaging Grading Comparison and Lesion Classification lists – Aug 2018
Key achievements of the year cont.
8 I ANNUAL REPORT 2019 ACHIEVEMENTS
Clinical Radiology
ACT
Jatinder Shekhawat
Melissa Craft
Bhagya Ratna Tekula
Wen Ter Kan
NSW
Brendan Coghlan
Diederick De Boo
Timothy Shore
Jaw Tzeng Tronidjaja
Manish Chug
Grace Aw
Edwin Ho
Guy Harris
Glyn Llewellyn-Jones
Gabrielle James
Seung Wook Ryu
Chandra Annabattula
Hayden Bell
Hao Xiang
Emmy De Heer
Louise Van Camp
Sweta Shalini
Geetha Ramaswami
Matthew Mouat
NT
Ahmed Bilal
QLD
Gregory Lock
Arjuna Somasundaram
Yu-Ting Huang
Bradley Wray
William McKenzie
Christian Acksteiner
Bernadette Wong
David Oar
Syed Zaheer
Sarah Cherian
Michael Tuppin
John Hilton
Rajeev Deva
Arani Halder
Brendon May
Vinicius Carraro Do Nascimento
Pradeep Sonwalkar
Gorane Santamaria Hormaechea
SA
James Bewes
Felix Paterson
Edward Wang
Andrew Low
Scott Luxton
Thomas Paxton
Tyler Munk
Tanushree Bhattacharjya
Sarah Faithfull
TAS
Emma Young
Jennifer Shoobridge
Jessica Monkhorst
VIC
Jason Wong
Doreen Quan
Chau Nguyen
Aaron Ow
Pieter Wood
Shyam Sankaran
Anthony Cardin
Ashley Rossiter
Andrew Hely
Kenneth Sim
Shu Yi Tan
Melissa Cheng
Cheng Lin Ting
Jonathan Dillon
Gary Tan
Ana Brusic
Heather Pascoe
Eliza Preece
Jeffrey Lai
Mandy Ren
Abigail Chong
Megan Ang
Angeline Ng
Chatura Wijetunga
Bob Tran
Simeon Babawale
Weeragoda Gamage Wijesinghe
Chester Chong
Farhan Ahmed
Muhammad Idris
Liyanaarachchi Silva
Dylan Kurda
Hong Kok
WA
Ruvini Gunawardana
Balaji Kodivalasa
Susan-Mary O'Hanlon
Samuel Gane
Charles Werren
Jayant Kumar
Sven Klinken
David Serich
Madusha Chandratilleke
Priyank Sheshagiri Chatra
Gerard O'Sullivan
Jacobus Otto
Pallavi Byrapu
Stella Jo
NZ
Neda Maani
Eliot Bishop
Debbie Yeh
Shane Lee
Hemanth Subramaniam
Lee Young
Anthony Harris
Chinthaka De Silva
Samuel Toner
Terina Caughey
Sonal Amin
Daniel Cornfeld
Kathy Wyant
Claudia Weidekamm
William Howard
Shane Diers
Albert Eshun
Singapore
Siska Muljadi
Overseas
Aradhna Raj
Zerlene Lim
Marjanne Descamps
Mallikarjunappa
Jing Zhou
Olivia Chin
Neelika Kirihetti Liyanage
Sean Mcilhone
Verash Bhagwandas
Heba Abdelrahman
Christopher Cassady
Paul Parizel
Radiation OncologyACT
Timothy Squire
NSW
Vicky Chin
Ro'ya Merie
Gina Hesselberg
Kin Sang Lam
Eun Ji Hwang
Kimberley Nguyen
Shreya Armstrong
NT
Saad Maqsood
Jonathon Hutton
QLD
Edward Sia
Gishan Ratnayake
Joanne Castelli
Hon Trinh
Michael Huo
Yuvnik Trada
NZ
Zhun Jeat Lee
Singapore
Michelle Tseng
New Fellows
NEW FELLOWS ANNUAL REPORT 2019 I 9
Support from our Members and Sponsors
The College is very grateful to the following Fellows and Members who have donated to the annual appeals for the Education Fund, the Research Fund and the JP Trainor Archive Trust. We also thank those members who declined to have their donations recognised.
Dr Firdaus Abd Rahim
A/Prof Brendan Adler
Dr Verity Ahern
Dr Suzan Bahadir
Dr Diana Balog
Dr Gillian Beveridge
Dr Krishna Bharat Boddupalli
Dr David Boshell
Dr Nicholas Brown
Dr David Byram
Dr York Cheung
Dr Sheetal Dhote
Dr Colin Dicks
Dr Peter Downey
Dr John Eng
Dr Richard Foster
Dr Patrick Galvin
Dr Peter Gendall
Dr Daniel Gierhake
Dr John Gimpel
Adj C/Prof Andrea Glynn
Dr Stacy Goergen
Dr Nirdosh Gogna
Dr Mary-Louise Greer
Dr Madhu Gulati
Dr Rebecca Hall
Dr Leigh Harvey
Dr Shabeer Hassam
Dr Peter Henderson
Dr Aneequa Hussain
Dr Muhammad Idris
Clin A/Prof Deepak Jain
Dr Sanjay Jeganathan
Dr Sandeep Joshi
Prof Solokara Karunarathne
Dr Lizbeth Kenny
Dr Shahroz Khan
Dr Alan Klevansky
Dr Ratna Koyyalamudi
Dr Maren Krueger
College Donors
AstraZeneca
AbbVie Pty Ltd
Accuray Asia Limited
AlphaXRT
Avant
Bayer Australia Ltd
BOQ Specialist
Brainlab
Camhealth
Cancer Institute NSW
Canon Medical Systems ANZ Pty Limited
Carestream
Carl Zeiss Pty Ltd
Central Data Networks Pty Ltd
Claremont Health Equipment Finance
Comrad Medical Systems
CorTechs Labs
Culpan Medical Pty Ltd
Diagnostic Imaging Australia
DPI Medical New Zealand Limited
EIZO
Elekta Pty Ltd
European Society of Radiology
Everlight Radiology
EverX Pty Ltd
GE Healthcare
GenesisCare
GRC Surgical
Guerbet Australia
Healthcare Imaging Services
Healthinc Pty Ltd
Hologic (Australia) Pty Ltd
Hyland
IBM Watson Health
ICON Group
Imaxeon Pty. Ltd.
I-MED Radiology Network
Integral Diagnostics
Intelerad Medical Systems
Kestral
Kiwis STAT Ltd
Macquarie Bank
Medtronic Australasia Pty Ltd
Mundipharma Pty Ltd
Pacific Radiology Group
Philips Healthcare
QScan
Radiation Oncology Private Practice Fund Administration
Radiology DU Ltd
Radius Imaging
Siemens Healthcare Limited
Siemens Healthineers
SKG Radiology, Sonic Healthcare
Varian Medical Systems
Volpara Solutions
Voyager Imaging Waikato DHB
We acknowledge the valuable support provided during the year by our supporters and sponsors.
Dr Ashok Kumar
Dr Numan Kutaiba
Dr Jan Labuscagne
Dr Aleksandra Lange
Dr Margaret Latham
Dr Melissa Lea
Dr Philip Lew
Dr Kian Lim
Dr Glen Lo
Dr Ronny Low
Dr Karthik Marripudi
Dr Thomas Mathews
Dr Ky McGrillen
A/Prof Salim Merchant
Dr Christopher Milross
Dr Manish Mittal
Dr Deepali Nandurkar
Dr Kenneth Neale
Dr Katherine Neville
Dr Kim-Son Nguyen
Dr Luke Oakden-Rayner
Dr Inna Page
Dr Amanda Palmer
Dr Geoffrey Peretz
Dr Richard Perry
Dr John Quayle
Dr Tulasi Ramanarasiah
Dr Vinicius Resende
Dr Ian Revfem
Dr Joseph Richter
Dr Donald Robertson
Dr Patricia Robertson
Dr Daniel Sampaio Vieira
Dr Darrel Sargeant
Dr Giuseppe Sasso
Dr Christine Shearman
Dr Darryl Shnier
Dr Fariha Sitheeque
Dr Piyush Siwach
Dr Paul Smith
Dr Pradeep Sonwalkar
Dr Peter Stein
Dr Abdul Tahir
Dr Keen Hun Tai
Dr Julius Tamangani
Dr Simon Tang
Dr Stephen Thompson
Dr Mahdi Timasi
Dr Lourens Rasmus Van Der Westhuizen
Dr John Stephen Vedelago
Clin Prof Arthur Vellios
Dr Michael Veness
Dr Denise Warner
Dr Philip Weeks
Dr Garvin Williamsz
Dr Alan Wise
Dr Nazanin Zarerad
10 I ANNUAL REPORT 2019 SPONSOR AND MEMBER SUPPORT
Financial Performance in 2018-2019
The Financial Statements for the year ending 30 June 2019, along with the auditor’s report are presented in this document. Detailed versions can be found on the College website www.ranzcr.com.
The College’s current financial objective is to achieve a breakeven result, excluding extraordinary projects of special significance. Funding of these projects has been set aside from the cash reserves built up over the last several years (referred to as ‘Accumulated funds’ in the accounts).
Investment in our training programs continued through a comprehensive reform of Training and Assessment, which followed the earlier review findings of the ACER/Prideaux report (2014). This work and investment is nearing completion and is moving to full implementation phase, which is scheduled for 2021 academic year. The financial impact of the reform in the current financial year is $654,621 which is in line with the budget for the reform agenda.
The net income after the Training and Assessment Reform project results in a net surplus of $440,633 for 2018- 2019. A significant contribution to the financial year’s surplus is attributed to the performance in the College’s investments. The College has retained
Donations and Other Support
The College is grateful for the support it received from its Fellows, members, corporate supporters and associated organisations throughout the year: detailed acknowledgement is available on page 10 of this report.
The College is also very grateful to Fellows and members who have donated to the Education and Research Fund annual appeal.
Without the generous pro bono assistance by so many members and Fellows, the cost of maintaining and growing the scope and the excellence of the College would require serious fee increases. We thank the Fellows who have contributed their time for the voluntary work and keep our costs contained by supporting training, examinations and a host of other activities.
surpluses of $7,713,871 which while small compared to the larger Royal Colleges, act as a financial buffer, and have provided investment and capital improvement gains that helped us to minimise fee increases.
The implementation of Training and Assessment Reform will remain an important area of College investment. Concurrently the College is working on IT platforms that will support the implementation of training and CPD reforms. IT costs will continue to be a major expense for the College as the rapidly changing environment dictates, we need to maintain the security, reliability and improve efficiency of the College’s programs. The timely and rigorous attention given to our IT platforms means that we are getting best value for member dollars.
Advocacy
The focus on Advocacy remained high during the election year with increased level of activities. The social and financial outcomes are satisfying for both our members and patients alike. However, ongoing interaction with policy and stakeholders to ensure timely and quality implementation of these changes will be crucial to bring these new policies to fruition.
A great intangible aspect of our positive approach to Advocacy has been further projected mitigation of perceived risk of RANZCR’s standing and image in medical practice, public and government perception.
Program Funding
The Specialist Training Program continues to be funded by grants from the Australian Department of Health. Most of the project is covering the College’s overhead costs to produce the outcomes required. The funding will continue until the end of the current contract in December 2021.
Membership Subscriptions
The Board determined that for 2019 - 2020 annual subscription should be set at $2,795 for Fellows and Educational Affiliates. The fee will assist in covering our ongoing expenses and will contribute to the long-term financial viability of the College.
Treasurer’s Report
Dr Peter Prattan
TREASURER'S REPORT ANNUAL REPORT 2019 I 11
Auditor’s Letter
Grant Thornton Audit Pty Ltd ACN 130 913 594 a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389 ‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to Grant Thornton Australia Limited. Liability limited by a scheme approved under Professional Standards Legislation.
www.grantthornton.com.au
Level 17, 383 Kent Street Sydney NSW 2000 Correspondence to: Locked Bag Q800 QVB Post Office Sydney NSW 1230 T +61 2 8297 2400 F +61 2 9299 4445 E [email protected] W www.grantthornton.com.au
Independent Auditor’s Report To the Members of The Royal Australian and New Zealand College of Radiologists
Report on the audit of the financial report
Opinion
We have audited the financial report of The Royal Australian and New Zealand College of Radiologists (the “Registered Entity”), which comprises the statement of financial position as at 30 June 2019, the statement of profit or loss and other comprehensive income, statement of changes in funds and statement of cash flows for the year then ended, and notes to the financial statements, including a summary of significant accounting policies and the Responsible Entities’ declaration.
In our opinion, the financial report of The Royal Australian and New Zealand College of Radiologists has been prepared in accordance with Division 60 of the Australian Charities and Not-for-profits Commission Act 2012, including:
1. giving a true and fair view of the Registered Entity’s financial position as at 30 June 2019 and of its financial performance for the year period then ended; and
2. complying with Australian Accounting Standards and Division 60 of the Australian Charities and Not-for-profits Commission Regulation 2013.
Basis for opinion
We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Report section of our report. We are independent of the Registered Entity in accordance with the ethical requirements of the Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for Professional Accountants (the Code) that are relevant to our audit of the financial report in Australia. We have also fulfilled our other ethical responsibilities in accordance with the Code.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
12 I ANNUAL REPORT 2019 AUDITOR'S LETTER
Responsibilities of the Responsible Entities for the financial report
The Responsible Entities of the Registered Entity are responsible for the preparation and fair presentation of the financial report in accordance with Australian Accounting Standards and the Australian Charities and Not-for-profits Commission Act, and for such internal control as the Responsible Entities determine is necessary to enable the preparation of the financial report that is free from material misstatement, whether due to fraud or error.
In preparing the financial report, the Responsible Entities are responsible for assessing the Registered Entity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Responsible Entities either intend to liquidate the Registered Entity or to cease operations, or have no realistic alternative but to do so.
Those charged with governance are responsible for overseeing the Registered Entity’s financial reporting process.
Auditor’s responsibilities for the audit of the financial report
Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of this financial report.
As part of an audit in accordance with the Australian Auditing Standards, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
• Identify and assess the risks of material misstatement of the financial report, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Registered Entity’s internal control.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Responsible Entities.
• Conclude on the appropriateness of the Responsible Entities use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Registered Entity’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial report or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Registered Entity to cease to continue as a going concern.
• Evaluate the overall presentation, structure and content of the financial report, including the disclosures, and whether the financial report represents the underlying transactions and events in a manner that achieves fair presentation.
AUDITOR'S LETTER ANNUAL REPORT 2019 I 13
Auditor’s Letter cont.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Grant Thornton Audit Pty Ltd Chartered Accountants
James Winter Partner – Audit & Assurance
Sydney, 6 September 2019
14 I ANNUAL REPORT 2019 AUDITOR'S LETTER
Grant Thornton Audit Pty Ltd ACN 130 913 594 a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389 ‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to Grant Thornton Australia Limited. Liability limited by a scheme approved under Professional Standards Legislation.
www.grantthornton.com.au
Level 17, 383 Kent Street Sydney NSW 2000 Correspondence to: Locked Bag Q800 QVB Post Office Sydney NSW 1230 T +61 2 8297 2400 F +61 2 9299 4445 E [email protected] W www.grantthornton.com.au
Auditor’s Independence Declaration To the Responsible Entities of The Royal Australian and New Zealand College of Radiologists
In accordance with the requirements of section 60-40 of the Australian Charities and Not-for-profits Commission Act 2012, as lead auditor for the audit of The Royal Australian and New Zealand College of Radiologists for the year ended 30 June 2019, I declare that, to the best of my knowledge and belief, there have been no contraventions of any applicable code of professional conduct in relation to the audit.
Grant Thornton Audit Pty Ltd Chartered Accountants
James Winter Partner – Audit & Assurance Sydney, 6 September 2019
AUDITOR'S LETTER ANNUAL REPORT 2019 I 15
Financials STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 30 JUNE 2019
NOTE 2019 2018
Operating activities: $ $
REVENUE
Member subscription income 8,610,813 8,062,047
Project funding 814,951 696,572
Annual Scientific Meeting income 1,663,062 1,628,440
Examination fees 1,987,266 1,776,356
Education and training fees 1,255,439 583,891
Fees 834,701 618,633
Course fees 770,225 1,156,210
Other revenue 3 723,740 703,850
16,660,197 15,225,999
EXPENSES
Employee benefits expense (7,780,906) (6,766,452)
Project costs (60,840) (84,462)
Council and Committee costs (2,736,139) (2,528,016)
Annual Scientific Meeting costs (1,268,040) (1,307,628)
Printing, publicity and public relations (310,875) (219,704)
Professional, consulting and legal fees (1,393,742) (1,619,554)
Journal production and postage (287,896) (319,113)
Occupancy costs (377,047) (336,773)
Depreciation and amortisation expense 7 (338,425) (313,585)
Accounting and audit fees (65,651) (63,769)
Interest expense (3,044) -
Other expenses (1,832,586) (1,662,440)
(16,455,191) (15,221,496)
Surplus before other operating expenses and revenue from investments and interest
205,006 4,503
Interest and investment income 883,693 703,553
Other operating expenses
Training and assessment reform (654,621) (536,437)
Surplus for the year 434,078 171,619
Other comprehensive income
Foreign currency translation 6,555 2,458
Other comprehensive income for the year 6,555 2,458
Total comprehensive income for the year 440,633 174,077
This statement should be read in conjunction with the notes to the financial statements.
16 I ANNUAL REPORT 2019 FINANCIALS
STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2019
NOTE 2019 2018
ASSETS $ $
CURRENT
Cash and cash equivalents 4 3,379,843 3,198,019
Trade and other receivables 5 591,644 426,316
Financial assets 8 2,849,846 7,155,259
Other assets 6 624,169 453,203
TOTAL CURRENT ASSETS 7,445,502 11,232,797
NON-CURRENT
Property, plant and equipment 7 3,670,080 3,927,302
Financial assets 8 17,382,637 10,643,104
TOTAL NON-CURRENT ASSETS 21,052,717 14,570,406
TOTAL ASSETS 28,498,219 25,803,203
LIABILITIES
CURRENT
Trade and other payables 9 4,086,528 2,937,389
Employee benefits 10 690,696 563,085
Other financial liabilities 11 13,081,588 12,048,543
TOTAL CURRENT LIABILITIES 17,858,812 15,549,017
NON-CURRENT
Employee benefits 10 134,255 189,667
TOTAL NON-CURRENT LIABILITIES 134,255 189,667
TOTAL LIABILITIES 17,993,067 15,738,684
NET ASSETS 10,505,152 10,064,519
FUNDS
Reserves 12 2,791,281 3,058,929
Accumulated funds 7,713,871 7,005,590
TOTAL FUNDS 10,505,152 10,064,519
This statement should be read in conjunction with the notes to the financial statements.
FINANCIALS ANNUAL REPORT 2019 I 17
STATEMENT OF CHANGES IN FUNDS FOR THE YEAR ENDED 30 JUNE 2019
Notes ReservesAccumulated
fundsTotal funds
$ $ $
Balance at 1 July 2017 2,998,589 6,891,853 9,890,442
Surplus for the year - 171,619 171,619
Other comprehensive income 2,458 - 2,458
Total comprehensive income for the year 2,458 171,619 174,077
Transfers from accumulated funds to reserves 57,882 (57,882) -
Balance at 30 June 2018 12 3,058,929 7,005,590 10,064,519
Balance at 1 July 2018 3,058,929 7,005,590 10,064,519
Surplus for the year - 434,078 434,078
Other comprehensive income 6,555 - 6,555
Total comprehensive income for the year 6,555 434,078 440,633
Transfers from reserve to accumulated funds (274,203) 274,203 -
Balance at 30 June 2019 12 2,791,281 7,713,871 10,505,152
This statement should be read in conjunction with the notes to the financial statements.
Financials cont.
18 I ANNUAL REPORT 2019 FINANCIALS
STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 JUNE 2019
Notes 2019 2018
CASH FLOWS FROM OPERATING ACTIVITIES $ $
Receipts from grants and managed government program 10,325,214 10,008,185
Receipts from members 9,471,894 8,736,926
Receipts from exam and assessments 5,104,494 5,410,339
Other receipts 954,410 2,939,777
Interest expense paid (3,044) -
Payments to suppliers and employees (24,046,069) (21,456,552)
Net cash provided by operating activities 16 1,806,899 5,638,675
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment 7 (81,203) (268,440)
Net purchase of financial assets (2,434,120) (5,556,763)
Interest and investment income 883,693 703,553
Net cash used in investing activities (1,631,630) (5,344,907)
CASH FLOWS FROM FINANCING ACTIVITIES
Net cash from financing activities - -
Net change in cash and cash equivalents 175,269 293,768
Cash and cash equivalents, beginning of year 3,198,019 2,901,793
Effects of exchange rate changes on cash and cash equivalents 6,555 2,458
Cash and cash equivalents, end of year 4 3,379,843 3,198,019
This statement should be read in conjunction with the notes to the financial statements.
Member Subscriptions59%
Exam Fees14%
Training & Img Fees14%
Events7%
Sponsorship1%
Other4%
RANZCR INCOME
Training & Assessment32%
Events, Publications And Member Services
18%
Policy, Advocacy, Media, Analytics & Governance23%
Standards & CPD20%
Research3%
Other1%
JMIRO3%
RANZCR EXPENDITURE
FINANCIALS ANNUAL REPORT 2019 I 19
Sydney OfficeLevel 9, 51 Druitt Street, Sydney NSW 2000, Australia. ABN 37 000 029 863T +61 2 9268 9777 | F + 61 2 9268 9799 | E [email protected] | www.ranzcr.edu.au
Wellington OfficeFloor 6, 142 Lambton Quay, Wellington, New Zealand T +64 4 472 6470 | F +64 4 472 6474 | E [email protected]
Copyright for this publication rests with The Royal Australian and New Zealand College of Radiologists®
College Grants Awards and Prizes Awarded 2019
ASM Prize Recipients
Clinical RadiologyWiley Best Exhibit Award – Radiology Dr Martin Blake
Branch of Origin Dr Sheila Oh
I-Med Best Emergency Radiology Scientific Exhibit Prize Dr George Harisis
Radiation Oncology Varian Medical Systems Educational Grants Dr Kylie Lopes FloroDr Revadhi ChelvarajahDr Tao XingDr Robert DuvenageDr Mihir ShankerDr Anna GubbinsDr Girish ShahDr Christopher Cowling
Varian Prize Dr Nicholas Bucknell
Wiley Best Exhibit Award – Radiation Oncology Dr Craig Wilson
Chris Atkinson Award – Best Radiation Oncology Scientific Paper Presentation A/Prof David Pryor
Elekta Award – the advances in the use of technology in Radiation Therapy Dr Trang Pham
David Wigg Prize for Radiobiology Research Dr Joseph Sia
College and Sponsored HonoursRoentgen MedalAdj Clinical Professor Stacy Goergen
Denise Lonergan Educational Service AwardDr Marcus Dreosti
Clinical Radiology Educational Service AwardA/Prof Bruno Giuffre
Thomas Baker FellowshipDr Kartika Bhatia
Trans-Tasman Radiation Oncology Group (TROG) Dr Michael LiDr Wee Loon OngDr Tze Kok
Examination PrizesC.E. Eddy Prize – Radiation OncologyDr Su Chen Fong
C.E. Eddy Prize – Clinical RadiologyDr Troy Wooding
H.R. Sear Prize – Clinical RadiologyDr Sally Ayesa
M.G.F. Donnan PrizeDr Shane Hyun Lee
Research Prizes and GrantsFaculty of Radiology Oncology Bourne and Langlands PrizeDr Michelle Tseng
Withers and Peters GrantDr Joseph Sia
Clinical Radiology Early Career Researchers AwardDr Michael Chan
Clinical Radiology Research GrantsA/Prof Frank GaillardDr Arian Lasocki
Radiation Oncology Research GrantsDr Kylie Lopes FloroDr David KokDr Sweet Ping Ng
It is with regret that we record the deaths of the following members during the year under review:
Dr Stephen Williams Educational Affiliate NZDr Merl De Silva Fellow TASAssociate Professor Robin Gibson Life NZDr Ezra Berley Educational Affiliate NSWDr Jerzy Mirecki Fellow NSWDr John Maxwell Fellow OverseasDr Neville Myers Fellow SA
Dr Frederick Jensen Life TASDr James Stackpool Fellow NSWDr Vimala Nayanar Fellow NSWDr William Benson Life SAProf Albert Lam Life NSWDr Michael Ti Fellow VICDr Edward Johnston Fellow QLDDr Sean Skea Fellow NZ
Deceased members